newsfilter
← Latest News
Business Wire·

Graphite Bio Announces Participation in Upcoming Cowen 42nd Annual Health Care Conference

Graphite Bio, Inc. (NASDAQ:GRPH), a clinical-stage, next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases, announced today that Josh Lehrer, M.D., chief executive officer of Gr